Verified earnings results
Denali Therapeutics Q3 2026 Earnings Results
Direct answer
Denali Therapeutics reported Q3 2026 results on November 3, 2026.
Revenue was 17,780,000. EPS missed the estimate by 17.95%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Denali Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 3, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -0.5426
- Reported EPS
- -0.64
- Revenue
- 17,780,000
- EPS surprise
- EPS missed the estimate by 17.95%.
Explore related company data
Read the frequently asked questions.
When did Denali Therapeutics report Q3 2026 earnings?
Denali Therapeutics reported on November 3, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Denali Therapeutics?
The verified record provides an EPS estimate of -0.5426.
Has Denali Therapeutics reported the Q3 2026 result?
Revenue was 17,780,000. EPS missed the estimate by 17.95%.
Which source supports this Denali Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.